HEALEY ALS Platform Trial - Regimen C CNM-Au8

Investigator: Stanley Appel, MD

Study Coordinator: Bing Liao

Status: Enrolling

ClinicalTrials.gov Number: NCT04414345

Phone: 713.363.7310

Protocol Number: PRO00025616


The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen C will evaluate the safety and efficacy of a single study drug, CNM-Au8, in participants with ALS.
More to Explore